Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Brenda Shank"'
Autor:
Susan Budinger, John Ellerton, Brenda Shank, Frank H. Valone, Neal J. Meropol, Thomas A. Colacchio, Robert J. Mayer, Richard M. Goldberg, Donna Niedzwiecki, Joel E. Tepper, Jeannette M. Day, Judy Hopkins
Publikováno v:
Journal of Clinical Oncology. 26:3229-3234
Purpose Although most patients with anal canal cancer are cured with sphincter-preserving, nonsurgical, combined-modality therapy, those with large tumors and lymph node involvement have a poor prognosis. To establish the safety and efficacy of induc
Autor:
Hyman B. Muss, Lauren Schnaper, Thomas J. Smith, Kevin S. Hughes, Charles L. Shapiro, Eric P. Winer, Clifford A. Hudis, Donald A. Berry, Larry Norton, Barbara L. Smith, Constance Cirrincione, Brenda Shank, Beryl McCormick, I. Craig Henderson, William C. Wood, David J. Sugarbaker, Judith Wheeler, Lorraine A. Champion
Publikováno v:
New England Journal of Medicine. 351:971-977
BACKGROUND In women 70 years of age or older who have early breast cancer, it is unclear whether lumpectomy plus tamoxifen is as effective as lumpectomy followed by tamoxifen plus radiation therapy. METHODS Between July 1994 and February 1999, we ran
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 48:1291-1299
Purpose: To determine the patterns of evaluation and treatment in the U.S. of women with early breast cancer treated with breast-conserving surgery and irradiation in 1993–94, and to compare these with a similar survey in 1983 and with the 1992 Sta
Autor:
Brenda Shank
Publikováno v:
Cancer Investigation. 16:397-404
Although the best TBI-containing regimen may not yet have been found, data suggest that for greatest leukemic cell kill with minimum morbidity, a highly fractionated TBI regimen (10-13 fractions) to a high total dose (14-15 Gy) may be optimum. Bu-Cy
Autor:
Hugo Castro-Malaspina, Alfred P. Gillio, N A Kernan, Joel A. Brochstein, Neal Flomenberg, Joseph Laver, Barrett H. Childs, Farid Boulad, Zvi Fuks, P Black, James W. Young, Richard J. O’Reilly, Brenda Shank
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 29:847-854
To assess the immunosuppressive capacity of hyperfractionated total lymphoid irradiation and cyclophosphamide for transplantation of unmodified allogeneic marrow in sensitized aplastic anemia patients.From February 1983 to September 1990, 23 multiply
Autor:
Mark G. Kris, J. Kutcher, Howard I. Scher, Nael Martini, J. Gaynor, Brenda Shank, John G. Armstrong
Publikováno v:
American Journal of Clinical Oncology. 14:285-290
Advances in the treatment of limited small-cell lung cancer (L-SCLC) have led to improved short-term outcome. However, it is not clear how well this predicts the ultimate fate of the patients. This may be affected by late relapse of SCLC, the develop
Autor:
B. Emami, Lawrence R. Coia, Brenda Shank, James A. Purdy, J.M. Manolis, John E. Munzenrider, Glenn D. Barest, Karen P. Doppke, E. Cheng, John W. Matthews, James M. Galvin, Thomas LoSasso
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 21:217-227
The experience of four institutions involved in a three-dimensional treatment planning contract (NCI) for lung cancer is described. It was found that three-dimensional treatment planning has a significant potential for optimization of treatment plans
Autor:
Linda J. Brewster, Miljenko V. Pilepich, Brenda Shank, Joel E. Tepper, Marcia Urie, Robert E. Drzymala, E. Cheng, J.M. Manolis, Lawrence J. Solin, Thomas LoSasso, Chandra Burman, James C.H. Chu
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 21:253-265
The role of three-dimensional (3-D) treatment planning for postoperative radiation therapy was evaluated for rectal carcinoma as part of an NCI contract awarded to four institutions. It was found that the most important contribution of 3-D planning f
Publikováno v:
Cancer. 66:844-847
Fourteen patients whose augmented or reconstructed breasts were treated with radiation therapy were analyzed. Silicone gel implants were used in 13 patients and free-injected silicone in one patient. The total radiation dose ranged from 4400 to 6200